LIVER INSTITUTE OF VIRGINIA

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Pilot Study to Treat Patients With Chronic Hepatitis C Virus (HCV) Genotype 1 and End-Stage Renal Disease (ESRD)

Phase 4

Conditions: Chronic Hepatitis C
End Stage Renal Disease

Interventions: Drug: Ribavirin
Drug: Peginterferon
Drug: Boceprevir

First Posted Date: 2012-11-21

Last Posted Date: 2012-11-22

Lead Sponsor: Liver Institute of Virginia

Target Recruit Count: 20

Registration Number: NCT01731301

Locations: 🇺🇸
Liver Institute of Virginia, Richmond, Virginia, United States

Prev
1
Next

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy